Mylan Pharms Inc Company Profile

✉ Email this page to a colleague

▶ Start for $1
Remove trial restrictions

MYLAN PHARMS INC has one hundred and four approved drugs.

There are twenty-one tentative approvals on MYLAN PHARMS INC drugs.

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan Pharms Inc	SILDENAFIL CITRATE	sildenafil citrate	TABLET;ORAL	201150-001	Nov 9, 2012	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Mylan Pharms Inc	LEVETIRACETAM	levetiracetam	TABLET, EXTENDED RELEASE;ORAL	200475-003	Dec 7, 2015		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Mylan Pharms Inc	VALSARTAN AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; valsartan	TABLET;ORAL	078020-004	Sep 21, 2012	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Mylan Pharms Inc	CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE	amitriptyline hydrochloride; chlordiazepoxide	TABLET;ORAL	071297-001	Dec 10, 1986	AB	RX	No	Yes		See Plans and Pricing				See Plans and Pricing
Mylan Pharms Inc	DONEPEZIL HYDROCHLORIDE	donepezil hydrochloride	TABLET;ORAL	090521-002	May 31, 2011		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mylan Pharms Inc	AVITA	tretinoin	CREAM;TOPICAL	020404-003	Jan 14, 1997	4,971,800	See Plans and Pricing
Mylan Pharms Inc	AVITA	tretinoin	CREAM;TOPICAL	020404-003	Jan 14, 1997	5,045,317	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.